deltatrials
Completed EARLY_PHASE1 NCT01143558

Searching for Persistence of Infection in Lyme Disease

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions Lyme Disease
Interventions Lyme Disease Xenodiagnosis
Updated 69 times since 2017 Last updated: Feb 14, 2026 Started: Nov 4, 2010 Primary completion: Dec 30, 2014 Completion: Dec 30, 2014

This EARLY_PHASE1 trial investigates Lyme Disease and is currently completed. National Institute of Allergy and Infectious Diseases (NIAID) leads this study, which shows 69 recorded versions since 2010 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

69 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed EARLY_PHASE1

  2. Jan 2026 — Feb 2026 [monthly]

    Completed EARLY_PHASE1

  3. Dec 2025 — Jan 2026 [monthly]

    Completed EARLY_PHASE1

  4. Nov 2025 — Dec 2025 [monthly]

    Completed EARLY_PHASE1

  5. Oct 2025 — Nov 2025 [monthly]

    Completed EARLY_PHASE1

▶ Show 64 earlier versions

  1. Jul 2025 — Oct 2025 [monthly]

    Completed EARLY_PHASE1

  2. Jun 2025 — Jul 2025 [monthly]

    Completed EARLY_PHASE1

  3. May 2025 — Jun 2025 [monthly]

    Completed EARLY_PHASE1

  4. Apr 2025 — May 2025 [monthly]

    Completed EARLY_PHASE1

  5. Mar 2025 — Apr 2025 [monthly]

    Completed EARLY_PHASE1

  6. Jan 2025 — Mar 2025 [monthly]

    Completed EARLY_PHASE1

  7. Dec 2024 — Jan 2025 [monthly]

    Completed EARLY_PHASE1

  8. Nov 2024 — Dec 2024 [monthly]

    Completed EARLY_PHASE1

  9. Oct 2024 — Nov 2024 [monthly]

    Completed EARLY_PHASE1

  10. Sep 2024 — Oct 2024 [monthly]

    Completed EARLY_PHASE1

  11. Aug 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  12. Jul 2024 — Aug 2024 [monthly]

    Completed EARLY_PHASE1

  13. Jun 2024 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

  14. May 2024 — Jun 2024 [monthly]

    Completed EARLY_PHASE1

  15. Apr 2024 — May 2024 [monthly]

    Completed EARLY_PHASE1

  16. Mar 2024 — Apr 2024 [monthly]

    Completed EARLY_PHASE1

  17. Feb 2024 — Mar 2024 [monthly]

    Completed EARLY_PHASE1

  18. Dec 2023 — Feb 2024 [monthly]

    Completed EARLY_PHASE1

  19. Nov 2023 — Dec 2023 [monthly]

    Completed EARLY_PHASE1

  20. Oct 2023 — Nov 2023 [monthly]

    Completed EARLY_PHASE1

  21. Sep 2023 — Oct 2023 [monthly]

    Completed EARLY_PHASE1

  22. Aug 2023 — Sep 2023 [monthly]

    Completed EARLY_PHASE1

  23. May 2023 — Aug 2023 [monthly]

    Completed EARLY_PHASE1

  24. Feb 2023 — May 2023 [monthly]

    Completed EARLY_PHASE1

  25. Jan 2023 — Feb 2023 [monthly]

    Completed EARLY_PHASE1

  26. Dec 2022 — Jan 2023 [monthly]

    Completed EARLY_PHASE1

  27. Sep 2022 — Dec 2022 [monthly]

    Completed EARLY_PHASE1

  28. Jul 2022 — Sep 2022 [monthly]

    Completed EARLY_PHASE1

  29. Jun 2022 — Jul 2022 [monthly]

    Completed EARLY_PHASE1

  30. May 2022 — Jun 2022 [monthly]

    Completed EARLY_PHASE1

  31. Apr 2022 — May 2022 [monthly]

    Completed EARLY_PHASE1

  32. Mar 2022 — Apr 2022 [monthly]

    Completed EARLY_PHASE1

  33. Feb 2022 — Mar 2022 [monthly]

    Completed EARLY_PHASE1

  34. Dec 2021 — Feb 2022 [monthly]

    Completed EARLY_PHASE1

  35. Nov 2021 — Dec 2021 [monthly]

    Completed EARLY_PHASE1

  36. Oct 2021 — Nov 2021 [monthly]

    Completed EARLY_PHASE1

  37. Sep 2021 — Oct 2021 [monthly]

    Completed EARLY_PHASE1

  38. Jun 2021 — Sep 2021 [monthly]

    Completed EARLY_PHASE1

  39. Apr 2021 — Jun 2021 [monthly]

    Completed EARLY_PHASE1

  40. Mar 2021 — Apr 2021 [monthly]

    Completed EARLY_PHASE1

  41. Feb 2021 — Mar 2021 [monthly]

    Completed EARLY_PHASE1

  42. Jan 2021 — Feb 2021 [monthly]

    Completed EARLY_PHASE1

  43. Oct 2020 — Jan 2021 [monthly]

    Completed EARLY_PHASE1

  44. Sep 2020 — Oct 2020 [monthly]

    Completed EARLY_PHASE1

  45. Aug 2020 — Sep 2020 [monthly]

    Completed EARLY_PHASE1

  46. Jul 2020 — Aug 2020 [monthly]

    Completed EARLY_PHASE1

  47. May 2020 — Jul 2020 [monthly]

    Completed EARLY_PHASE1

  48. Jan 2020 — May 2020 [monthly]

    Completed EARLY_PHASE1

  49. Dec 2019 — Jan 2020 [monthly]

    Completed EARLY_PHASE1

  50. Nov 2019 — Dec 2019 [monthly]

    Completed EARLY_PHASE1

  51. Oct 2019 — Nov 2019 [monthly]

    Completed EARLY_PHASE1

  52. Aug 2019 — Oct 2019 [monthly]

    Completed EARLY_PHASE1

  53. Apr 2019 — Aug 2019 [monthly]

    Completed EARLY_PHASE1

  54. Mar 2019 — Apr 2019 [monthly]

    Completed EARLY_PHASE1

  55. Feb 2019 — Mar 2019 [monthly]

    Completed EARLY_PHASE1

  56. Jan 2019 — Feb 2019 [monthly]

    Completed EARLY_PHASE1

  57. Dec 2018 — Jan 2019 [monthly]

    Completed EARLY_PHASE1

  58. Nov 2018 — Dec 2018 [monthly]

    Completed EARLY_PHASE1

  59. Aug 2018 — Nov 2018 [monthly]

    Completed EARLY_PHASE1

  60. Jun 2018 — Aug 2018 [monthly]

    Completed EARLY_PHASE1

  61. May 2018 — Jun 2018 [monthly]

    Completed EARLY_PHASE1

  62. May 2017 — May 2018 [monthly]

    Completed EARLY_PHASE1

  63. Feb 2017 — May 2017 [monthly]

    Completed EARLY_PHASE1

    Phase: Phase 0 → EARLY_PHASE1

  64. Jan 2017 — Feb 2017 [monthly]

    Completed Phase 0

    First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bethesda, United States
  • • Boston, United States
  • • New Haven, United States